{"product_id":"harvard-dementia-a-comprehensive-update-2026","title":"Harvard Dementia A Comprehensive Update 2026","description":"\u003ch1 data-section-id=\"iazrxj\" data-start=\"0\" data-end=\"47\"\u003eHarvard Dementia: A Comprehensive Update 2026\u003c\/h1\u003e\r\n\u003ch2 data-section-id=\"sikm1b\" data-start=\"49\" data-end=\"137\"\u003eComprehensive Advances in Dementia Diagnosis, Biomarkers, Treatment, and Patient Care\u003c\/h2\u003e\r\n\u003cp data-start=\"139\" data-end=\"816\"\u003e\u003cstrong data-start=\"139\" data-end=\"188\"\u003eHarvard Dementia: A Comprehensive Update 2026\u003c\/strong\u003e is one of the most respected educational programs dedicated to the diagnosis, management, prevention, and emerging treatment of Alzheimer's disease and related neurodegenerative disorders. Organized by leading cognitive neurologists and dementia specialists from Harvard Medical School and affiliated institutions, this intensive multidisciplinary course provides clinicians with the latest evidence-based approaches to cognitive impairment, mild cognitive impairment (MCI), Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal degeneration, Parkinsonian dementias, and other neurodegenerative conditions.\u003c\/p\u003e\r\n\u003cp data-start=\"818\" data-end=\"1262\"\u003eDesigned for healthcare professionals involved in dementia care, this comprehensive review combines advances in clinical practice, neuroimaging, biomarkers, neuropsychology, disease-modifying therapies, caregiver support, neuroethics, and end-of-life care. Participants gain practical strategies to improve diagnostic accuracy, optimize treatment decisions, and enhance quality of life for patients and families affected by cognitive disorders.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"1264\" data-end=\"1267\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1sp67mj\" data-start=\"1269\" data-end=\"1287\"\u003eCourse Overview\u003c\/h2\u003e\r\n\u003cp data-start=\"1289\" data-end=\"1508\"\u003eThe global burden of dementia continues to rise as populations age, creating an urgent need for clinicians to remain current with rapidly evolving diagnostic technologies, biomarkers, treatment options, and care models.\u003c\/p\u003e\r\n\u003cp data-start=\"1510\" data-end=\"1949\"\u003eNow in its 29th year, \u003cstrong data-start=\"1532\" data-end=\"1573\"\u003eDementia: A Comprehensive Update 2026\u003c\/strong\u003e provides a thorough review of the full spectrum of cognitive disorders, from preclinical Alzheimer's disease and mild cognitive impairment to advanced dementia. The course integrates foundational neuroscience, clinical diagnosis, biomarker interpretation, pharmacologic and non-pharmacologic therapies, caregiver support strategies, and emerging disease-modifying treatments.\u003c\/p\u003e\r\n\u003cp data-start=\"1951\" data-end=\"2170\"\u003eA major focus of the 2026 program is the expanding role of biomarkers and newly approved disease-modifying therapies for Alzheimer's disease, helping clinicians understand how these advances are reshaping dementia care.\u003c\/p\u003e\r\n\u003cp data-start=\"2172\" data-end=\"2204\"\u003e\u003cstrong data-start=\"2172\" data-end=\"2188\"\u003eCourse Date:\u003c\/strong\u003e May 27–30, 2026\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"2206\" data-end=\"2209\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1kb8ddg\" data-start=\"2211\" data-end=\"2238\"\u003eComprehensive Curriculum\u003c\/h2\u003e\r\n\u003ch3 data-section-id=\"100ygon\" data-start=\"2240\" data-end=\"2263\"\u003eAlzheimer's Disease\u003c\/h3\u003e\r\n\u003cp data-start=\"2265\" data-end=\"2286\"\u003eParticipants explore:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"2288\" data-end=\"2541\"\u003e\r\n \t\u003cli data-section-id=\"xbdsoi\" data-start=\"2288\" data-end=\"2325\"\u003eAlzheimer's disease pathophysiology\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1mxw801\" data-start=\"2326\" data-end=\"2351\"\u003eAmyloid and tau biology\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"wjzb4y\" data-start=\"2352\" data-end=\"2376\"\u003eClinical presentations\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"kwroop\" data-start=\"2377\" data-end=\"2421\"\u003eTypical and atypical Alzheimer's syndromes\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"15x4kb5\" data-start=\"2422\" data-end=\"2443\"\u003eDisease progression\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"vypv85\" data-start=\"2444\" data-end=\"2458\"\u003eRisk factors\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1k6n8mr\" data-start=\"2459\" data-end=\"2482\"\u003ePrevention strategies\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"8g8olg\" data-start=\"2483\" data-end=\"2511\"\u003eEarly detection approaches\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"8ju20s\" data-start=\"2512\" data-end=\"2541\"\u003eDisease-modifying therapies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2543\" data-end=\"2622\"\u003eFaculty discuss the latest developments in Alzheimer's diagnosis and treatment.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"2624\" data-end=\"2627\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1idox02\" data-start=\"2629\" data-end=\"2664\"\u003eMild Cognitive Impairment (MCI)\u003c\/h3\u003e\r\n\u003cp data-start=\"2666\" data-end=\"2684\"\u003eCoverage includes:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"2686\" data-end=\"2848\"\u003e\r\n \t\u003cli data-section-id=\"1iaz6d8\" data-start=\"2686\" data-end=\"2707\"\u003eDiagnostic criteria\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ol8tqp\" data-start=\"2708\" data-end=\"2729\"\u003eClinical evaluation\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"xjdaqb\" data-start=\"2730\" data-end=\"2751\"\u003eRisk stratification\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"17nttqg\" data-start=\"2752\" data-end=\"2776\"\u003eProgression prediction\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"50ye0p\" data-start=\"2777\" data-end=\"2800\"\u003eMonitoring strategies\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"eh3du8\" data-start=\"2801\" data-end=\"2824\"\u003eBiomarker integration\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1nt4sb\" data-start=\"2825\" data-end=\"2848\"\u003eManagement approaches\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2850\" data-end=\"2927\"\u003eParticipants learn evidence-based approaches to identifying and managing MCI.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"2929\" data-end=\"2932\"\u003e\r\n\r\n\u003ch3 data-section-id=\"l07foo\" data-start=\"2934\" data-end=\"2957\"\u003eDementia Biomarkers\u003c\/h3\u003e\r\n\u003cp data-start=\"2959\" data-end=\"2988\"\u003eExtensive instruction covers:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"2990\" data-end=\"3170\"\u003e\r\n \t\u003cli data-section-id=\"13fcdu0\" data-start=\"2990\" data-end=\"3022\"\u003eCerebrospinal fluid biomarkers\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"11gfauo\" data-start=\"3023\" data-end=\"3044\"\u003eAmyloid PET imaging\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"yz2nrf\" data-start=\"3045\" data-end=\"3062\"\u003eTau PET imaging\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"fypg7r\" data-start=\"3063\" data-end=\"3081\"\u003eMRI applications\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1rnhytd\" data-start=\"3082\" data-end=\"3091\"\u003eFDG-PET\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1g61yej\" data-start=\"3092\" data-end=\"3116\"\u003eBlood-based biomarkers\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"4ho4ys\" data-start=\"3117\" data-end=\"3143\"\u003eBiomarker interpretation\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"hfuuu7\" data-start=\"3144\" data-end=\"3170\"\u003eAppropriate use criteria\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3172\" data-end=\"3260\"\u003eClinicians learn how biomarkers can improve diagnostic precision and treatment planning.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"3262\" data-end=\"3265\"\u003e\r\n\r\n\u003ch3 data-section-id=\"18wrpeg\" data-start=\"3267\" data-end=\"3298\"\u003eNeurodegenerative Dementias\u003c\/h3\u003e\r\n\u003cp data-start=\"3300\" data-end=\"3325\"\u003eDetailed reviews include:\u003c\/p\u003e\r\n\r\n\u003ch4 data-start=\"3327\" data-end=\"3363\"\u003eDementia with Lewy Bodies (DLB)\u003c\/h4\u003e\r\n\u003cul data-start=\"3365\" data-end=\"3500\"\u003e\r\n \t\u003cli data-section-id=\"1i5e5wg\" data-start=\"3365\" data-end=\"3384\"\u003eClinical features\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"exkb6m\" data-start=\"3385\" data-end=\"3401\"\u003eHallucinations\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ddal5l\" data-start=\"3402\" data-end=\"3426\"\u003eCognitive fluctuations\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"gvcpxd\" data-start=\"3427\" data-end=\"3456\"\u003eREM sleep behavior disorder\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1wlcp88\" data-start=\"3457\" data-end=\"3477\"\u003eBiomarker findings\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"190qy0h\" data-start=\"3478\" data-end=\"3500\"\u003eTreatment strategies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4 data-start=\"3502\" data-end=\"3536\"\u003eFrontotemporal Dementia (FTD)\u003c\/h4\u003e\r\n\u003cul data-start=\"3538\" data-end=\"3638\"\u003e\r\n \t\u003cli data-section-id=\"1anj12g\" data-start=\"3538\" data-end=\"3562\"\u003eBehavioral variant FTD\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"dw6un4\" data-start=\"3563\" data-end=\"3592\"\u003ePrimary progressive aphasia\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"x27ggg\" data-start=\"3593\" data-end=\"3614\"\u003eClinical phenotypes\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"17mwdlr\" data-start=\"3615\" data-end=\"3638\"\u003eDiagnostic challenges\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4 data-start=\"3640\" data-end=\"3679\"\u003eParkinson's Disease Dementia (PDD)\u003c\/h4\u003e\r\n\u003cul data-start=\"3681\" data-end=\"3757\"\u003e\r\n \t\u003cli data-section-id=\"mdyqy3\" data-start=\"3681\" data-end=\"3707\"\u003eCognitive manifestations\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"15x4kb5\" data-start=\"3708\" data-end=\"3729\"\u003eDisease progression\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1mr0r1a\" data-start=\"3730\" data-end=\"3757\"\u003eManagement considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4 data-start=\"3759\" data-end=\"3799\"\u003eVascular Cognitive Impairment (VCI)\u003c\/h4\u003e\r\n\u003cul data-start=\"3801\" data-end=\"3890\"\u003e\r\n \t\u003cli data-section-id=\"xgvt14\" data-start=\"3801\" data-end=\"3824\"\u003eVascular risk factors\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1yl61i4\" data-start=\"3825\" data-end=\"3843\"\u003eImaging findings\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1k6n8mr\" data-start=\"3844\" data-end=\"3867\"\u003ePrevention strategies\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"3uaa18\" data-start=\"3868\" data-end=\"3890\"\u003eTreatment approaches\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"3892\" data-end=\"3895\"\u003e\r\n\r\n\u003ch3 data-section-id=\"a2rzji\" data-start=\"3897\" data-end=\"3930\"\u003eNeuropsychological Assessment\u003c\/h3\u003e\r\n\u003cp data-start=\"3932\" data-end=\"3952\"\u003eParticipants review:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"3954\" data-end=\"4198\"\u003e\r\n \t\u003cli data-section-id=\"vh2f59\" data-start=\"3954\" data-end=\"3981\"\u003eCognitive screening tools\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"52144f\" data-start=\"3982\" data-end=\"4020\"\u003eMontreal Cognitive Assessment (MoCA)\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"17uhdsi\" data-start=\"4021\" data-end=\"4054\"\u003eMental Status Examination (MSE)\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"19cne1s\" data-start=\"4055\" data-end=\"4083\"\u003eNeuropsychological testing\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"qs924\" data-start=\"4084\" data-end=\"4113\"\u003eCognitive domain assessment\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"195g5hi\" data-start=\"4114\" data-end=\"4150\"\u003eInterpretation of testing patterns\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"n5h6yq\" data-start=\"4151\" data-end=\"4198\"\u003eDifferential diagnosis of cognitive disorders\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4200\" data-end=\"4249\"\u003ePractical office-based approaches are emphasized.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"4251\" data-end=\"4254\"\u003e\r\n\r\n\u003ch3 data-section-id=\"giom3f\" data-start=\"4256\" data-end=\"4284\"\u003eNeuroimaging in Dementia\u003c\/h3\u003e\r\n\u003cp data-start=\"4286\" data-end=\"4301\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"4303\" data-end=\"4483\"\u003e\r\n \t\u003cli data-section-id=\"ji8ioz\" data-start=\"4303\" data-end=\"4319\"\u003eStructural MRI\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"g1hdtx\" data-start=\"4320\" data-end=\"4340\"\u003eFunctional imaging\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1jfnab5\" data-start=\"4341\" data-end=\"4358\"\u003eAmyloid imaging\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1i4ekay\" data-start=\"4359\" data-end=\"4372\"\u003eTau imaging\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"139ai91\" data-start=\"4373\" data-end=\"4401\"\u003eNeurodegenerative patterns\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"hcdxzi\" data-start=\"4402\" data-end=\"4440\"\u003eDifferential diagnosis using imaging\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1tefxj8\" data-start=\"4441\" data-end=\"4483\"\u003eClinical integration of imaging findings\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"4485\" data-end=\"4488\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1e8pavi\" data-start=\"4490\" data-end=\"4525\"\u003eNew Disease-Modifying Therapies\u003c\/h3\u003e\r\n\u003cp data-start=\"4527\" data-end=\"4564\"\u003eA major focus of the course includes:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"4566\" data-end=\"4749\"\u003e\r\n \t\u003cli data-section-id=\"15z2zut\" data-start=\"4566\" data-end=\"4607\"\u003eRecently approved Alzheimer's therapies\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"5rjr23\" data-start=\"4608\" data-end=\"4633\"\u003eAnti-amyloid treatments\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1v51imz\" data-start=\"4634\" data-end=\"4653\"\u003ePatient selection\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"a5i9xd\" data-start=\"4654\" data-end=\"4676\"\u003eMonitoring protocols\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"gor1pt\" data-start=\"4677\" data-end=\"4700\"\u003eSafety considerations\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1y5zerk\" data-start=\"4701\" data-end=\"4718\"\u003eARIA management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"rj73uw\" data-start=\"4719\" data-end=\"4749\"\u003eFuture therapeutic pipelines\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4751\" data-end=\"4840\"\u003eParticipants gain practical guidance on integrating new therapies into clinical practice.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"4842\" data-end=\"4845\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1wrd6fc\" data-start=\"4847\" data-end=\"4891\"\u003eBehavioral and Neuropsychiatric Symptoms\u003c\/h3\u003e\r\n\u003cp data-start=\"4893\" data-end=\"4911\"\u003eCoverage includes:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"4913\" data-end=\"5056\"\u003e\r\n \t\u003cli data-section-id=\"2ae8fi\" data-start=\"4913\" data-end=\"4924\"\u003eAgitation\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"42s1o6\" data-start=\"4925\" data-end=\"4937\"\u003eAggression\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1pkmdly\" data-start=\"4938\" data-end=\"4950\"\u003eDepression\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1cgr4ri\" data-start=\"4951\" data-end=\"4960\"\u003eAnxiety\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1wlsmfx\" data-start=\"4961\" data-end=\"4969\"\u003eApathy\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"3z7m7z\" data-start=\"4970\" data-end=\"4981\"\u003ePsychosis\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1xczi5u\" data-start=\"4982\" data-end=\"5002\"\u003eSleep disturbances\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"3t3ecf\" data-start=\"5003\" data-end=\"5029\"\u003eBehavioral interventions\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"j4m6xq\" data-start=\"5030\" data-end=\"5056\"\u003ePharmacologic management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5058\" data-end=\"5129\"\u003eFaculty emphasize non-pharmacologic strategies as first-line treatment.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"5131\" data-end=\"5134\"\u003e\r\n\r\n\u003ch3 data-section-id=\"qnxua0\" data-start=\"5136\" data-end=\"5166\"\u003eDementia Caregiver Support\u003c\/h3\u003e\r\n\u003cp data-start=\"5168\" data-end=\"5185\"\u003eSessions explore:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"5187\" data-end=\"5346\"\u003e\r\n \t\u003cli data-section-id=\"1adngs8\" data-start=\"5187\" data-end=\"5205\"\u003eCaregiver burden\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"qi7qr7\" data-start=\"5206\" data-end=\"5225\"\u003eFamily counseling\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"wwpt24\" data-start=\"5226\" data-end=\"5255\"\u003eStress reduction strategies\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1kl9xqa\" data-start=\"5256\" data-end=\"5277\"\u003eCommunity resources\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1akmudt\" data-start=\"5278\" data-end=\"5292\"\u003eRespite care\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1l35b30\" data-start=\"5293\" data-end=\"5313\"\u003eLong-term planning\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"t3buaw\" data-start=\"5314\" data-end=\"5346\"\u003eImproving caregiver resilience\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"5348\" data-end=\"5351\"\u003e\r\n\r\n\u003ch3 data-section-id=\"6u4dj8\" data-start=\"5353\" data-end=\"5395\"\u003eChronic Traumatic Encephalopathy (CTE)\u003c\/h3\u003e\r\n\u003cp data-start=\"5397\" data-end=\"5417\"\u003eParticipants review:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"5419\" data-end=\"5513\"\u003e\r\n \t\u003cli data-section-id=\"1i5e5wg\" data-start=\"5419\" data-end=\"5438\"\u003eClinical features\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"vypv85\" data-start=\"5439\" data-end=\"5453\"\u003eRisk factors\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1xsankk\" data-start=\"5454\" data-end=\"5470\"\u003eNeuropathology\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"17mwdlr\" data-start=\"5471\" data-end=\"5494\"\u003eDiagnostic challenges\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"rekuky\" data-start=\"5495\" data-end=\"5513\"\u003eCurrent evidence\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"5515\" data-end=\"5518\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1whbwvd\" data-start=\"5520\" data-end=\"5551\"\u003eDelirium and Encephalopathy\u003c\/h3\u003e\r\n\u003cp data-start=\"5553\" data-end=\"5568\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"5570\" data-end=\"5713\"\u003e\r\n \t\u003cli data-section-id=\"i300x\" data-start=\"5570\" data-end=\"5595\"\u003eRecognition of delirium\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1i72e3u\" data-start=\"5596\" data-end=\"5620\"\u003eDifferential diagnosis\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1k6n8mr\" data-start=\"5621\" data-end=\"5644\"\u003ePrevention strategies\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1nt4sb\" data-start=\"5645\" data-end=\"5668\"\u003eManagement approaches\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1y0blm9\" data-start=\"5669\" data-end=\"5713\"\u003eRelationship between delirium and dementia\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"5715\" data-end=\"5718\"\u003e\r\n\r\n\u003ch3 data-section-id=\"euwczr\" data-start=\"5720\" data-end=\"5752\"\u003eNeuroethics and Legal Issues\u003c\/h3\u003e\r\n\u003cp data-start=\"5754\" data-end=\"5784\"\u003eImportant discussions include:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"5786\" data-end=\"5968\"\u003e\r\n \t\u003cli data-section-id=\"u3eyxl\" data-start=\"5786\" data-end=\"5808\"\u003eCapacity assessments\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1o4qhfw\" data-start=\"5809\" data-end=\"5831\"\u003eFinancial competence\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1wi6knx\" data-start=\"5832\" data-end=\"5848\"\u003eDriving safety\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"5zww15\" data-start=\"5849\" data-end=\"5863\"\u003eGuardianship\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1v2qjiy\" data-start=\"5864\" data-end=\"5887\"\u003eAdvance care planning\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"7yq759\" data-start=\"5888\" data-end=\"5913\"\u003eDisclosure of diagnosis\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"icutue\" data-start=\"5914\" data-end=\"5932\"\u003eInformed consent\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1483m15\" data-start=\"5933\" data-end=\"5968\"\u003eEthical dilemmas in dementia care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"5970\" data-end=\"5973\"\u003e\r\n\r\n\u003ch3 data-section-id=\"mf5w3z\" data-start=\"5975\" data-end=\"6010\"\u003ePalliative and End-of-Life Care\u003c\/h3\u003e\r\n\u003cp data-start=\"6012\" data-end=\"6030\"\u003eCoverage includes:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"6032\" data-end=\"6175\"\u003e\r\n \t\u003cli data-section-id=\"1audmn2\" data-start=\"6032\" data-end=\"6062\"\u003eAdvanced dementia management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"15ey0t2\" data-start=\"6063\" data-end=\"6077\"\u003eHospice care\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"j92h5m\" data-start=\"6078\" data-end=\"6098\"\u003eSymptom management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ia9y1\" data-start=\"6099\" data-end=\"6117\"\u003ePain recognition\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"qz6ivl\" data-start=\"6118\" data-end=\"6145\"\u003eGoals-of-care discussions\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1wwfkz6\" data-start=\"6146\" data-end=\"6175\"\u003eEnd-of-life decision-making\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"6177\" data-end=\"6180\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1scsphp\" data-start=\"6182\" data-end=\"6204\"\u003eLearning Objectives\u003c\/h2\u003e\r\n\u003cp data-start=\"6206\" data-end=\"6267\"\u003eUpon completion of this course, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"6269\" data-end=\"7046\"\u003e\r\n \t\u003cli data-section-id=\"15drgaa\" data-start=\"6269\" data-end=\"6345\"\u003eDifferentiate normal aging, MCI, Alzheimer's disease, and other dementias.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1pnfa30\" data-start=\"6346\" data-end=\"6415\"\u003eApply current Alzheimer's Association clinical practice guidelines.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"vngvze\" data-start=\"6416\" data-end=\"6495\"\u003eUtilize cognitive screening tools and neuropsychological testing effectively.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"gxkpuk\" data-start=\"6496\" data-end=\"6558\"\u003eIntegrate biomarkers into dementia diagnosis and management.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1krbuy9\" data-start=\"6559\" data-end=\"6621\"\u003eInterpret MRI, PET, CSF, and blood-based biomarker findings.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"d2wirl\" data-start=\"6622\" data-end=\"6700\"\u003eEvaluate newly approved disease-modifying therapies for Alzheimer's disease.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"cht0c8\" data-start=\"6701\" data-end=\"6775\"\u003eImplement evidence-based pharmacologic and non-pharmacologic treatments.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"cai7we\" data-start=\"6776\" data-end=\"6837\"\u003eRecognize and manage neuropsychiatric symptoms of dementia.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"lyws8v\" data-start=\"6838\" data-end=\"6905\"\u003eSupport caregivers through education and practical interventions.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"hiqz24\" data-start=\"6906\" data-end=\"6976\"\u003eAddress medico-legal, ethical, and safety concerns in dementia care.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"troxoe\" data-start=\"6977\" data-end=\"7046\"\u003eApply palliative care principles throughout the dementia continuum.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"7048\" data-end=\"7051\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1cq7b5x\" data-start=\"7053\" data-end=\"7076\"\u003eEducational Features\u003c\/h2\u003e\r\n\u003cp data-start=\"7078\" data-end=\"7110\"\u003e✔ Harvard Medical School Faculty\u003c\/p\u003e\r\n\u003cp data-start=\"7112\" data-end=\"7143\"\u003e✔ Comprehensive Dementia Review\u003c\/p\u003e\r\n\u003cp data-start=\"7145\" data-end=\"7174\"\u003e✔ Alzheimer's Disease Updates\u003c\/p\u003e\r\n\u003cp data-start=\"7176\" data-end=\"7205\"\u003e✔ Dementia Biomarker Training\u003c\/p\u003e\r\n\u003cp data-start=\"7207\" data-end=\"7234\"\u003e✔ Amyloid \u0026amp; Tau PET Imaging\u003c\/p\u003e\r\n\u003cp data-start=\"7236\" data-end=\"7271\"\u003e✔ Disease-Modifying Therapy Updates\u003c\/p\u003e\r\n\u003cp data-start=\"7273\" data-end=\"7312\"\u003e✔ Neuropsychology and Cognitive Testing\u003c\/p\u003e\r\n\u003cp data-start=\"7314\" data-end=\"7345\"\u003e✔ Behavioral Symptom Management\u003c\/p\u003e\r\n\u003cp data-start=\"7347\" data-end=\"7377\"\u003e✔ Caregiver Support Strategies\u003c\/p\u003e\r\n\u003cp data-start=\"7379\" data-end=\"7413\"\u003e✔ Neuroethics and End-of-Life Care\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"7415\" data-end=\"7418\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1m9xcqo\" data-start=\"7420\" data-end=\"7438\"\u003eTarget Audience\u003c\/h2\u003e\r\n\u003cp data-start=\"7440\" data-end=\"7468\"\u003eThis course is designed for:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"7470\" data-end=\"7780\"\u003e\r\n \t\u003cli data-section-id=\"xos8wi\" data-start=\"7470\" data-end=\"7484\"\u003eNeurologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1javkkq\" data-start=\"7485\" data-end=\"7500\"\u003ePsychiatrists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ovv5rd\" data-start=\"7501\" data-end=\"7516\"\u003eGeriatricians\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1g5cfzw\" data-start=\"7517\" data-end=\"7542\"\u003ePrimary Care Physicians\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1vdecm\" data-start=\"7543\" data-end=\"7573\"\u003eInternal Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ooz55j\" data-start=\"7574\" data-end=\"7602\"\u003eFamily Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"3lqt0s\" data-start=\"7603\" data-end=\"7623\"\u003eNeuropsychologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ley5ht\" data-start=\"7624\" data-end=\"7646\"\u003ePhysician Assistants\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"rea4z6\" data-start=\"7647\" data-end=\"7668\"\u003eNurse Practitioners\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"oyy8zz\" data-start=\"7669\" data-end=\"7684\"\u003ePsychologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"xszxna\" data-start=\"7685\" data-end=\"7701\"\u003eSocial Workers\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ol1trt\" data-start=\"7702\" data-end=\"7727\"\u003eMemory Clinic Providers\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"9css9h\" data-start=\"7728\" data-end=\"7780\"\u003eHealthcare Professionals Involved in Dementia Care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"7782\" data-end=\"7785\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1pmm4cw\" data-start=\"7787\" data-end=\"7813\"\u003eWhy This Course Matters\u003c\/h2\u003e\r\n\u003cp data-start=\"7815\" data-end=\"8190\"\u003eThe landscape of dementia care is undergoing a historic transformation driven by advances in biomarkers, neuroimaging, disease-modifying therapies, and precision diagnostics. Clinicians must now integrate emerging technologies with comprehensive patient-centered care strategies that address cognitive symptoms, behavioral challenges, caregiver needs, and long-term planning.\u003c\/p\u003e\r\n\u003cp data-start=\"8192\" data-end=\"8513\"\u003e\u003cstrong data-start=\"8192\" data-end=\"8241\"\u003eHarvard Dementia: A Comprehensive Update 2026\u003c\/strong\u003e provides a practical, evidence-based framework for diagnosing and managing dementia across its entire spectrum, helping clinicians deliver more accurate diagnoses, individualized treatment plans, and improved outcomes for patients and families facing cognitive disorders.\u003c\/p\u003e\r\n\r\n\u003ch2 data-path-to-node=\"6\"\u003eTopics\u003c\/h2\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,0,0\"\u003eIntroduction to the Course\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,1,0\"\u003eHuman Cognition An Overview\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,2,0\"\u003eMemory Systems \u0026amp; Amnesia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,3,0\"\u003eNeuropathology of AD ADRD A Guide forPracticing Clinicians\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,4,0\"\u003eFrom Proteinopathies to Neuroimaging \u0026amp; Biomarkers in AD ADRD Primer on Practice and Advances\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,5,0\"\u003eAlzheimer’s Disease \u0026amp; Related Dementias Global Perspectives and Opportunities\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,6,0\"\u003eClinical Use of Blood Biomarkers in 2026 and Beyond\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,7,0\"\u003ePanel Discussion and Q\u0026amp;A Alireza Atri; Brad Dickerson\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,8,0\"\u003eAD Dementia Practical Evaluation \u0026amp; Managementin Clinical Practice\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,9,0\"\u003eMild Cognitive Impairment Prodromal AD and Beyond\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,10,0\"\u003eAdvances in AD Experimental Therapeutics + Panel Discussion and Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,11,0\"\u003eNeuropsychology of Aging\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,12,0\"\u003eAttentional and Executive Systems – Don’t Leave Home without Them\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,13,0\"\u003eFrontotemporal Dementias Focus on Behaviorall Executive Variants\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,14,0\"\u003eLanguage Systems \u0026amp; Aphasia-predominant Dementia Syndromes\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,15,0\"\u003eUpdates on Vascular Cognitive Impairment \u0026amp; Dementia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,16,0\"\u003ePanel Discussion and Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,17,0\"\u003eLewy Body Disease, and Parkinsonian \u0026amp; Sensorimotorpredominant Dementias\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,18,0\"\u003eAssessment of Cognition in Clinical Practice\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,19,0\"\u003ePractical Compensatory Strategies for Cognitive Decline\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,20,0\"\u003eAssessment of Daily Function and Neuropsychiatric Symptoms Behavior and Staging of Dementia in Practice\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,21,0\"\u003eCased-based Discussion of Lecanemab and Donanemab\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,22,0\"\u003ePanel Discussion and Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,23,0\"\u003eNon-Pharmacological Approaches to Neuropsychiatric Symptoms and Problem Behaviors in Dementia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,24,0\"\u003ePharmacological Management of Behavioral Problems in Dementia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,25,0\"\u003ePractical \u0026amp; Ethical Considerations for Disclosure of Demetia-Related Diagnosis and Risk\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,26,0\"\u003eCaregiving in Dementia Impact, Consequences \u0026amp; Opportunities\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,27,0\"\u003ePanel Discussion and Q\u0026amp;A\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,28,0\"\u003eCommunity Advocacy and Activism For Dementias\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,29,0\"\u003eChronic Traumatic Encephalopathy (CTE) \u0026amp; Dementia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,30,0\"\u003eDelirium, Encephalopathies and Uncommon Dementias\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,31,0\"\u003ePanel Discussion, Q\u0026amp;A and Conclusions\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,32,0\"\u003eDementia \u0026amp; The Law Clinical Pearls on Testamentary Capacity and Undue Influence\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,33,0\"\u003ePrinciples \u0026amp; Practice of Mental Capacity and Competence in Dementia From Finances to Firearms\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,34,0\"\u003eDriving, Home \u0026amp; Community Safety and Dementia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,35,0\"\u003eAdvance Care Planning \u0026amp; Management of End-stage Dementia, Pain, Palliation \u0026amp; Hospice in Long-Term Care\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,36,0\"\u003ePanel Discussion, Q \u0026amp; A, and conclusions\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43066692304994,"sku":"MED-AMB09460","price":100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Dementia-A-Comprehensive-Update-2026.jpg?v=1782499407","url":"https:\/\/meducourse.com\/products\/harvard-dementia-a-comprehensive-update-2026","provider":"Meducourse","version":"1.0","type":"link"}